Skip to main content
Equibles

NEUBERGER BERMAN GROUP LLC

Position in RDY — Dr Reddys Laboratories Ltd

CIK 1465109 NEW YORK, NY
Back to RDY Full portfolio

Position in RDY

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$665,829
-$643,576 QoQ
Shares Held
45,951
-51.4% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#95
of 238 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority Sole 37% Shared 0% None 63%

Common Shares in RDY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

NEUBERGER BERMAN GROUP LLC holds $273,087,606 across 29 Drug Manufacturers - Specialty & Generic names. RDY ranks #15 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PRGO
PERRIGO Co plc
 10,680,100 $110,966,238
2 AMRX
Amneal Pharmaceuticals, Inc.
 3,887,179 $67,287,068
3 ZTS
Zoetis Inc.
 634,661 $45,606,739
4 ALKS
Alkermes plc.
 260,208 $13,634,899
5 HIMS
Hims & Hers Health, Inc.
 188,748 $6,543,893
6 HLN
Haleon plc
 677,951 $6,325,282
7 VTRS
Viatris Inc
 279,144 $4,432,805
8 TEVA
Teva Pharmaceutical Industries Ltd
 115,560 $3,915,172

All Filings in RDY

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $665,829 45,951
2026-03-31 $1,309,405 94,542
2025-12-31 $1,356,136 96,591
2025-09-30 $1,748,324 125,059
2025-06-30 $3,179,280 211,529
2025-03-31 $938,797 71,175
2024-12-31 $1,152,653 72,999
2024-09-30 $1,185,631 14,923
2024-06-30 $811,803 10,655
2024-03-31 $5,040,904 68,724
2023-12-31 $6,669,243 95,850
2023-09-30 $5,105,724 76,353
2023-06-30 $683,859 10,836
2023-03-31 $2,014,581 35,387
2022-06-30 $531,134 9,589
2021-09-30 $4,830,586 74,157
2021-06-30 $9,589,305 130,449
2021-03-31 $8,668,574 141,205
2020-12-31 $9,448,990 132,543
2020-09-30 $2,736,351 39,338
2020-06-30 $519,922 9,808